Fred Hu serves as the Co-founder and CEO of GenBio AI, bringing a wealth of experience in strategic leadership, global investment, and innovation to the forefront of biotechnology and artificial intelligence. As the Founder, Chairman, and CEO of Primavera Capital Group, Fred has led transformative investments in companies such as Alibaba Group, ByteDance, and SenseTime, showcasing his ability to identify and support groundbreaking technologies. His tenure as Partner and Chairman of Greater China at Goldman Sachs further underscores his expertise in driving high-impact initiatives in complex markets. At GenBio AI, Fred leverages this unparalleled experience to shape a vision where AI and biology converge to redefine research and medical innovation.
Fred’s commitment to global progress extends beyond his professional accomplishments. He serves as the non-executive chairman of Yum China Holdings Inc. and sits on the boards of ICBC and UBS Group AG. Additionally, Fred is deeply involved in philanthropic and academic organizations, including The Nature Conservancy’s global Board of Directors, the China Medical Board, and Harvard University’s Global Advisory Council. With advanced degrees in Engineering from Tsinghua University and Economics from Harvard University, Fred combines technical acumen and strategic foresight to lead GenBio AI into a new era of scientific discovery.
Biography
Fred Hu serves as the Co-founder and CEO of GenBio AI, bringing a wealth of experience in strategic leadership, global investment, and innovation to the forefront of biotechnology and artificial intelligence. As the Founder, Chairman, and CEO of Primavera Capital Group, Fred has led transformative investments in companies such as Alibaba Group, ByteDance, and SenseTime, showcasing his ability to identify and support groundbreaking technologies. His tenure as Partner and Chairman of Greater China at Goldman Sachs further underscores his expertise in driving high-impact initiatives in complex markets. At GenBio AI, Fred leverages this unparalleled experience to shape a vision where AI and biology converge to redefine research and medical innovation.
Fred’s commitment to global progress extends beyond his professional accomplishments. He serves as the non-executive chairman of Yum China Holdings Inc. and sits on the boards of ICBC and UBS Group AG. Additionally, Fred is deeply involved in philanthropic and academic organizations, including The Nature Conservancy’s global Board of Directors, the China Medical Board, and Harvard University’s Global Advisory Council. With advanced degrees in Engineering from Tsinghua University and Economics from Harvard University, Fred combines technical acumen and strategic foresight to lead GenBio AI into a new era of scientific discovery.